AZD1981 + Neovletta 21/28 + Placebo AZD1981
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Oral Contraceptives
Conditions
Oral Contraceptives
Trial Timeline
May 1, 2010 → Oct 1, 2010
NCT ID
NCT01110525About AZD1981 + Neovletta 21/28 + Placebo AZD1981
AZD1981 + Neovletta 21/28 + Placebo AZD1981 is a phase 1 stage product being developed by AstraZeneca for Oral Contraceptives. The current trial status is completed. This product is registered under clinical trial identifier NCT01110525. Target conditions include Oral Contraceptives.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01110525 | Phase 1 | Completed |
Competing Products
20 competing products in Oral Contraceptives